Using facial recognition and AI to confirm medication adherence, AiCure raises .25M

AiCure, a company that combines video facial recognition and artificial intelligence to confirm that patients have taken their medication has raised a $12.25 million Series A round, according to a company statement. The fundraise underscores the diverse landscape of medication adherence strategies by technology companies. “Accurately understanding patient behavior through artificial intelligence defines a new category of medication adherence monitoring,” said Adam Hanina, AiCure CEO. New Leaf Venture Partners led the Series A round. Other participants included Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Adviser for Science and Technology to Bill Gates. The developers of AiCure’s technology have likened it to a personal trainer in a gym working directly with a client to achieve their goals. It involves facial recognition and…


Link to Full Article: Using facial recognition and AI to confirm medication adherence, AiCure raises .25M